Sign in

Private company

Hansa Biopharma

Logo: hansabiopharma.com4

Hansa Biopharma is a limited company registered in Sweden, based in Lund, founded in 2007.1

Hansa Biopharma AB (tidigare Hansa Medical AB) är ett svenskt läkemedesutvecklingsbolag. Det grundades 2001 och har sitt säte i Lund.2 From the Swedish Wikipedia, CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2007Founded1
  • HeadquartersLund, Sweden1
  • Websitewww.hansabiopharma.com
  • Legal formAktiebolag3
  • LEI549300LLEO25ZJJ3NT913
  • StatusActive3
  • LEI statusIssued and current3
  • Registered addressBox 785, 220 07 Lund, Sweden3
  • Registered withSwedish Companies Registration Office, 556734-53593

See how the biggest companies compare on our leaderboards

Timeline

  1. 2007Founded Founded1

Calendar

Drug trials and FDA: coming up

  1. Feb 28, 2027Phase 2 trial readout expected Phase 2 trial of Imlifidase in Kidney Transplantation in Highly Sensitized Patients: primary completion expected Feb 28, 2027 (ClinicalTrials.gov NCT05753930).5

Drug trials and FDA: recently

  1. Apr 21, 2026Phase 3 trial completed Phase 3 trial of Imlifidase in Kidney Transplantation in Highly Sensitized Patients: primary completion Apr 21, 2026, no results posted yet (ClinicalTrials.gov NCT05369975).6

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
    Company websiteHansa Biopharma logo
  5. 5
  6. 6